Search for: "A. G."
Results 8181 - 8200
of 65,602
Sorted by Relevance
|
Sort by Date
1 Mar 2010, 8:09 am
The ABA Journal Magazine online recently published an article by G. [read post]
2 Jun 2021, 10:20 am
Findley (Wisconsin; Google Scholar) & Louise G. [read post]
29 Jul 2021, 12:20 pm
William G. [read post]
27 Mar 2013, 1:15 pm
Tatarowicz (Georgetown) & William G. [read post]
23 May 2013, 11:52 am
Continue reading »Follow Above the Law on Twitter or become a fan on Facebook.Tags: Administrative Law, Antonin Scalia, Benchslap, Benchslaps, Chevron, Chevron deference, Constitutional Interpretation, Constitutional Law, Federal Government, John G. [read post]
22 Jun 2013, 2:00 am
Andrew G. [read post]
4 Jun 2016, 8:17 am
Contents include:Anne-Marie Carstens, The Hostilities-Occupation Dichotomy and Cultural Property in Non-International Armed ConflictsJulien Chaisse & Lisa Zhuoyue Li, Shareholder Protection Reloaded-- Redesigning the Matrix of Shareholder Claims for Reflective LossMichael G. [read post]
7 Feb 2008, 7:12 am
District Judge Richard G. [read post]
24 Jan 2008, 10:06 am
The news that a rogue trader at Société Générale, the French bank, somehow ran up a 4.9 billion euro ($7.2 billion) loss in stock index futures without management noticing is provoking incredulity at the World Economic Forum in Davos. [read post]
21 Jan 2010, 3:29 pm
Changing personnel record to indicate a resignation rather than a dismissed for cause not necessarily binding for purposes of unemployment insuranceMatter of Childs v Commissioner of Labor, 2010 NY Slip Op 00328, Appellate Division, Third Department [see, also, 42 AD3d 620]Marcita G. [read post]
11 Feb 2024, 10:00 pm
Partners Sheri Dillon and Jennifer Breen, with associates James G. [read post]
1 Jun 2009, 2:00 am
McConkey and another (Appellants) v The Simon Community (Respondents) (Northern Ireland) [2009] UKHL 24 (20 May 2009) Odelola (FC) (Appellant) v Secretary of State for the Home Department (Respondent) [2009] UKHL 25 (20 May 2009) R (on the application of G) (FC) (Appellant) v London Borough of Southwark (Respondents) [2009] UKHL 26 (20 May 2009) Smith (Appellant) v [...] [read post]
26 Jul 2024, 8:53 am
Horsey (Whether the defendants filed "at least two prior motions to open or other similar motion" pursuant to Practice Book § 61-11 (g), such that an automatic appellate stay did not apply to toll the running of the law days; whether the appeal is moot) [read post]
15 Aug 2024, 8:00 am
Persp. 3-136 (2024): William G. [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
18 Aug 2024, 10:00 pm
Recognizing the importance of diversity and inclusivity in clinical trials, drug development, and regulatory decision-making, Congress amended the Federal Food, Drug, and Cosmetic Act (FDCA) in connection with the Food and Drug Omnibus Reform Act (FDORA) provisions of the Consolidated Appropriations Act of 2023, requiring sponsors of certain clinical studies of drugs, biological products, and medical devices to submit Diversity Action Plans to the FDA (FDCA Sections 505(z) and 520(g)(9)). [read post]
